Yuflyma

Yuflyma is owned by Celltrion, Inc., headquartered in South Korea. No. The ultimate owner of Yuflyma, Celltrion, Inc., is headquartered in South Korea, not in the United States.

Celltrion is a major South Korean biopharmaceutical company specializing in the development and manufacturing of biosimilars and innovative biologics for the treatment of cancer, autoimmune diseases, and other conditions.

Celltrion USA (for the United States) or Celltrion Healthcare (global distribution)